SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
22 hedge funds and large institutions have $67M invested in Sierra Oncology, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
Holders
22
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$18.8M | |
| 2 | +$14.5M | |
| 3 | +$8.54M | |
| 4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$6.32M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$4.32M |
Top Sellers
| 1 | -$470K | |
| 2 | -$171K | |
| 3 | -$132K | |
| 4 |
GT
Greenleaf Trust
Kalamazoo,
Michigan
|
-$74K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$62K |